XOMAP Q1 2024 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M+241.0% YoY

Gross Profit

$1M99.9% margin

Operating Income

-$7M-470.1% margin

Net Income

-$9M-576.8% margin

EPS (Diluted)

$-0.86

QoQ Revenue Growth

-18.7%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$219M

Total Liabilities

$137M

Stockholders' Equity

$82M

Cash & Equivalents

$136M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$437,000	+241.0%
Gross Profit	$1M	$383,000	+288.5%
Operating Income	-$7M	-$10M	+31.1%
Net Income	-$9M	-$10M	+12.4%